Eli Lilly and Company (LLY) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Indianapolis, IN, United States. The current CEO is David A. Ricks.
LLY has IPO date of 1972-06-01, 47,000 full-time employees, listed on the NYSE, a market capitalization of $871.6B.
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a comprehensive portfolio of human pharmaceuticals across multiple therapeutic areas. The company's offerings span diabetes management with products like Humalog and Humulin insulins, oncology with agents including Alimta, Cyramza, and Verzenio for various cancers, immunology with Olumiant and Taltz for rheumatoid arthritis and psoriatic conditions, and neuroscience with medications such as Cymbalta and Zyprexa. Additionally, Eli Lilly provides treatments for other indications including erectile dysfunction, osteoporosis, and COVID-19, supported by strategic collaborations with leading biotechnology firms. Founded in 1876 and headquartered in Indianapolis, Indiana, the company maintains a strong commitment to innovation and therapeutic advancement across its diverse drug pipeline.
